Accreditations
Eramol Authorisations & Industry Accreditations
Trusted, Fully Compliant, and Globally Recognised
Authorised by Leading Regulatory Bodies
Eramol is a fully authorised and accredited organisation, recognised by major regulatory authorities across the UK, EU, and internationally. Our compliance with MHRA, HPRA, GDP, and WDA(v) standards demonstrates our commitment to quality, regulatory excellence, and continuous improvement in pharmaceutical manufacturing, storage, and distribution.
These authorisations give our clients confidence that every aspect of their clinical or commercial supply chain is handled in accordance with the highest industry standards.
Regulatory Authorisations
Eramol maintains a comprehensive suite of authorisations covering manufacturing, distribution, and controlled substances:
MHRA Manufacturing Authorisations
- MIA(IMP) 49160
- MIA 49160
- MS 49160
HPRA Manufacturing Authorisations
- MIA(IMP)
- MIA
MHRA GDP Authorisations
- WDA(h) 49160
- WDA(v) 49160
UK Home Office Licences (S1-S5)
- Supply, storage & production of controlled substances: 1063212
Why Eramol Authorisations Matter
Being fully authorised and accredited enables Eramol to:
- Operate globally with regulatory confidence, ensuring seamless supply across UK, EU, and worldwide markets
- Manufacture and store IMPs and commercial products in compliance with Good Manufacturing Practice (GMP) and Good Distribution Practice (GDP)
- Handle controlled substances safely and legally, including Schedule 1–5 products
- Provide clients with expert regulatory support, ensuring all projects meet current legislation and inspection requirements
Our team continuously monitors regulatory developments, ensuring Eramol remains at the forefront of compliance and quality assurance.
Trusted by Sponsors and Partners
Eramol’s accreditations reflect our reputation as a reliable and compliant partner for:
- Clinical trial sponsors and contract research organisations (CROs)
- Global pharmaceutical companies
- Supply chain and distribution partners requiring GDP-compliant services
- Projects involving controlled substances or high-risk IMPs
By choosing Eramol, clients benefit from industry-recognised authorisations, giving peace of mind and regulatory certainty throughout the product lifecycle.
Contact Eramol
Work with a fully authorised, compliant, and trusted pharmaceutical partner.
- Request Authorisation Details
- Speak to a Regulatory Expert
Tailored Solutions
Customer Focused
Flexible Approach
Global Presence
More About Us
Company
The company is privately owned. As a private equity-free company, Eramol is able to act in the best interests of the Company and its Clients, with a focus on service, delivery and innovation.
People
Eramol was founded on the shared values of the co-founders to offer a tailored and responsive clinical trial manufacturing services to sponsors with a wide set of requirements.
Our Approach
Eramol has developed a profound customer process that aims to deliver complete satisfaction to our clients at every stage.
Accreditations
Eramol is an authorised organisation across many strategic areas of the business. Accreditations relate to MHRA, HPRA, MHRA GDP and WDA(v). We work with all relevant bodies to ensure the very latest accreditations are in line with ongoing, continuous developments in the industry.